Eli Lilly and Company

Eli Lilly and Company

World Rank (Jul-30-2023)
16
Market Cap (Jul-30-2023)
435.22 Billion USD
World Rank (Dec-25-2022)
19
Market Cap (Dec-25-2022)
349.57 Billion USD
World Rank (Jan-07-2022)
39
Market Cap (Jan-07-2022)
248.24 Billion USD
World Rank (Jan-01-2021)
69
Market Cap (Jan-01-2021)
161.51 Billion USD
Company Rank in Country in 2023
Rank in USA in July-2023 is 13
Company Rank in Country in 2022
Rank in USA in 2022 is 25
World Region
Americas
World Subregion
Northern America
CEO
David A. Ricks
Chairman
Juan R. Luciano
Founders
Eli Lilly
Employee Count
39,000
Employee Count as of Date
As on 2022
Headquarters Country
USA
Headquarters City/State
Indiana
Annual Revenue in USD
28,541 Million USD
Annual Operating Income in USD
8,280 Million USD
Annual Net Income in USD
6,244 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
49,489 Million USD
Total Liabilities in USD
38,714 Million USD
Total Equity in USD
10,775 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector LC
Healthcare
Pharmaceutical
Biotechnology
HealthCare Products
Healthcare Service
Company Website
Eli Lilly And Company - Pharmaceutical Company
Wikipedia
Wikipedia
Yahoo
Yahoo @ NYSE
Facebook
Facebook
Company Profile

Eli Lilly is a healthcare and pharmaceutical company and is USA based MNC company. Key business areas are Oncology, Bio-Medicines, Diabetes and also Animals Health. Headquarters is in USA.

Facts About Lilly as on 2022:

  • Approximately 39,000 employees worldwide
  • Clinical research conducted in more than 55 countries
  • Research and development facilities located in 8 countries
  • Manufacturing plants located in 8 countries
  • Products marketed in 120 countries
Facts About Company

As on 2022, Eli Lilly has 39,000 employees.

Eli Lilly annual revenue generated for period ending Dec-2022 was 28,541 million USD.

Eli Lilly annual net income generated for period ending Dec-2022 was 6,244 million USD.

Eli Lilly annual revenue generated for period ending Dec-2021 was 28,318 million USD.

Eli Lilly annual net income generated for period ending Dec-2021 was 5,581 million USD.

Annual Results Summary LC

Eli Lilly and Company - Annual Revenue and Net Profit - in Million USD:

Year - EndingRevenueNet Profit
Dec-202228,5416,244
Dec-202128,3185,581
Dec-202024,5396,193
Dec-201922,3198,318
Dec-201824,5553,232
Dec-201722,871-204  (Loss)
Dec-201621,2222,737
Balance Sheet Summary LC

Eli Lilly and Company - Balance Sheet Summary - in Million USD:

Year Ending:Total AssetsTotal LiabilitiesTotal Equity
Dec-202249,48938,71410,775
Dec-202148,80639,6519,154
Dec-202046,63340,8075,641
Dec-201939,28636,5872,607
Dec-201843,90832,9999,829
Dec-201744,98133,31311,592
Dec-201638,80624,72514,008
Quarterly Results Summary LC

Eli Lilly and Company - Quarterly Revenue and Net Profit - in Million USD:

Quarter - EndingRevenueNet Profit
Sep-20239,498-57.4 (Loss)
Jun-20238,3121,763
Mar-20236,9601,345
Dec-20227,3011,937
Sep-20226,9411,451
Jun-20226,488952
Mar-20227,8101,902
Dec-20217,9991,726
Sep-20216,7721,110
Jun-20216,7401,390
Mar-20216,8051,355
Dec-20207,4402,116
Sep-20204,4141,208
Jun-20204,2771,412
Mar-20205,8591,456
Dec-20196,1141,495
Sep-20195,4761,253
Jun-20195,6361,327
Mar-20195,0924,241
Dec-20186,4381,125
Sep-20186,0611,149
Founded Year
1876
Institutional Investors

Top 30 Institutional Investors in ELI LILLY AND COMPANY as on SEP-30-2023

RANKINSTITUTION NAMEDATESHARES HELDCHANGE (SHARES)CHANGE (%)VALUE (IN 1,000S)
1LILLY ENDOWMENT INC09/30/20239,99,83,810-10,45,000-1.03%$61,072,111
2VANGUARD GROUP INC09/30/20237,05,75,6026,36,6940.91%$43,108,989
3BLACKROCK INC.09/30/20236,56,73,93412,21,9571.90%$40,114,952
4PNC FINANCIAL SERVICES GROUP, INC.09/30/20235,17,89,291-80,514-0.16%$31,633,935
5STATE STREET CORP09/30/20233,34,06,858-4,71,559-1.39%$20,405,577
6FMR LLC09/30/20233,21,87,472-6,89,613-2.10%$19,660,752
7CAPITAL WORLD INVESTORS09/30/20232,68,60,053-7,528-0.03%$16,406,658
8PRIMECAP MANAGEMENT CO/CA/09/30/20232,30,63,536-4,82,665-2.05%$14,087,669
9PRICE T ROWE ASSOCIATES INC /MD/09/30/20232,22,35,992-19,24,967-7.97%$13,582,189
10STATE FARM MUTUAL AUTOMOBILE INSURANCE CO09/30/20231,71,57,660-2,06,031-1.19%$10,480,242
11JPMORGAN CHASE & CO09/30/20231,58,03,19216,63,57811.77%$9,652,906
12GEODE CAPITAL MANAGEMENT, LLC09/30/20231,57,14,2255,08,7243.35%$9,598,563
13WELLINGTON MANAGEMENT GROUP LLP09/30/20231,28,54,465-15,96,844-11.05%$7,851,764
14MORGAN STANLEY06/30/20231,24,68,0753,05,6302.51%$7,615,750
15NORTHERN TRUST CORP09/30/20231,01,58,2753,55,3173.63%$6,204,878
16BANK OF AMERICA CORP /DE/09/30/202398,37,955-3,74,463-3.67%$6,009,220
17NORGES BANK12/31/202293,37,9787,72,6129.02%$5,703,824
18JENNISON ASSOCIATES LLC09/30/202384,07,613-1,73,825-2.03%$5,135,538
19BANK OF NEW YORK MELLON CORP09/30/202378,59,824-5,79,799-6.87%$4,800,938
20CAPITAL RESEARCH GLOBAL INVESTORS09/30/202372,52,2504,69,2736.92%$4,429,819
21CAPITAL INTERNATIONAL INVESTORS09/30/202361,39,754-59,018-0.95%$3,750,285
22LEGAL & GENERAL GROUP PLC09/30/202359,24,805-1,82,455-2.99%$3,618,989
23NUVEEN ASSET MANAGEMENT, LLC09/30/202352,74,7781,74,7533.43%$3,221,940
24ALLIANCEBERNSTEIN L.P.09/30/202349,15,5791,81,3513.83%$3,002,534
25GOLDMAN SACHS GROUP INC09/30/202348,39,056-716-0.02%$2,955,792
26FISHER ASSET MANAGEMENT, LLC09/30/202344,57,0742,18,7735.16%$2,722,470
27CHARLES SCHWAB INVESTMENT MANAGEMENT INC09/30/202344,35,31188,0162.03%$2,709,177
28AMUNDI09/30/202344,01,713-4,65,650-9.57%$2,688,654
29UBS ASSET MANAGEMENT AMERICAS INC09/30/202343,72,782-2,47,830-5.36%$2,670,983
30AMERIPRISE FINANCIAL INC09/30/202336,73,218-4,32,630-10.54%$2,243,675
Stock Category LC
S&P 500
Stock Exchange LC
NYSE
Bovespa Brazil
Switzerland
EURONEXT